×
About 22,733 results

ALLMedicine™ Pulmonary Fibrosis Center

Research & Reviews  10,955 results

"Hybrid Lung Transplantation" Combining Living Donor and Cadaveric Lung Transplants: Re...
https://doi.org/10.1016/j.transproceed.2021.04.019
Transplantation Proceedings; Kurosaki T, Oto T et. al.

Jun 13th, 2021 - We present 2 cases of "hybrid lung transplant," which included sequentially implanting a living lobar graft to 1 side and a cadaveric graft to the other side. This procedure was approved by the institutional review board at Okayama University Hosp...

Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice ...
https://doi.org/10.1016/j.intimp.2021.107780
International Immunopharmacology; Xiong Y, Cui X et. al.

Jun 12th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible inflammatory disease with a high mortality rate and limited therapeutic options. This study explored the potential role and mechanisms of Dehydrocostus lactone (DHL) in the inflamma...

Non-canonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.
https://doi.org/10.1165/rcmb.2020-0499OC
American Journal of Respiratory Cell and Molecular Biology; Liu T, Gonzalez De Los Santos F et. al.

Jun 9th, 2021 - The Wnt/β-catenin pathway initiates a signaling cascade critical in cell differentiation and normal development of multiple organ systems. The reactivation of this pathway has been documented in experimental and human idiopathic pulmonary fibrosis...

Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic rev...
https://doi.org/10.1186/s12931-021-01760-6 10.1183/13993003.01653-2015 10.1007/s12325-018-0693-1 10.1183/13993003.02279-2019 10.1164/rccm.201807-1255ST 10.1016/S1357-2725(96)00141-0 10.1165/rcmb.2020-0373PS 10.1378/chest.123.6.2007 10.1111/j.1440-1843.2005.00742.x 10.1016/j.rmed.2009.08.013 10.1016/j.rmed.2008.11.001 10.1016/j.biopha.2017.11.101 10.1038/s41591-018-0087-6 10.1007/s13205-020-02278-2 10.1038/s41467-019-10839-0 10.1159/000489668 10.1183/13993003.01188-2019 10.1001/jama.283.15.2008 10.1016/j.jclinepi.2009.06.005 10.1016/j.jclinepi.2007.10.007 10.1093/ije/dyn188 10.1136/bmj.315.7109.629 10.1016/j.rmed.2011.08.022 10.1378/chest.14-0041 10.1097/MD.0000000000005239 10.1183/09031936.00217614 10.1093/aje/152.4.307 10.1111/imj.15191 10.3389/fpubh.2020.00196 10.2337/dc07-1464 10.1159/000050509 10.2337/diacare.27.3.752 10.1016/j.metabol.2017.12.006 10.1378/chest.09-2622 10.1111/j.1464-5491.2010.03073.x 10.1007/s12013-014-0068-4 10.3346/jkms.2012.27.7.756 10.1159/000029331 10.1016/S0954-6111(97)90254-7 10.1007/BF00203738 10.1093/aje/kwi076 10.2337/diab.45.3.S77 10.1002/cbf.1418 10.1016/j.resp.2015.12.003 10.1016/j.jdiacomp.2006.08.004 10.1097/00003246-199608000-00004 10.1159/000111569 10.1183/09031936.00011810 10.1056/NEJM199411103311907 10.1513/pats.201203-023AW 10.1038/nrm3434 10.1016/S2213-8587(20)30365-X 10.1016/S2213-2600(20)30364-7 10.1016/j.cmet.2016.09.003 10.1164/rccm.201809-1700RR 10.1016/S2213-2600(17)30387-9 10.1038/ng.2609 10.1001/jama.2013.5827 10.1164/rccm.2009-040GL 10.1164/ajrccm.161.2.ats3-00
Respiratory Research; Bai L, Zhang L et. al.

Jun 9th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a chronic diffuse interstitial lung disease, of which the etiology has been poorly understood. Several studies have focused on the relationship between IPF and diabetes mellitus (DM) in the past years but hav...

The effect of pirfenidone on the prescription of antibiotics and antitussive drugs in p...
https://doi.org/10.1016/j.chest.2021.05.058
Chest Suzuki A, Sakaguchi H et. al.

Jun 8th, 2021 - The effect of pirfenidone on the prescription of antibiotics and antitussive drugs in patients with idiopathic pulmonary fibrosis: a post-hoc exploratory analysis of phase III clinical trial.|2021|Suzuki A,Sakaguchi H,Sakamoto K,Ebina M,Azuma A,|

see more →

Guidelines  29 results

S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis.
https://doi.org/10.1159/000512315
Respiration; International Review of Thoracic Diseases; Behr J, Günther A et. al.

Jan 24th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF requires considerable expertise and experience. Since the publication of the international IPF guideline in the year 2011 and the update 2018 several studies...

Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic ...
https://doi.org/10.5603/ARM.2020.0081
Advances in Respiratory Medicine; Piotrowski WJ, Bestry I et. al.

Mar 10th, 2020 - This document presents the guidelines of the Polish Respiratory Society (PTChP, Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), developed by agroup of Polish experts. The recommendations were de...

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice G...
https://www.atsjournals.org/doi/10.1164/rccm.201807-1255ST
Raghu, G.

Aug 31st, 2018 - This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and.

Evaluation of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society ...
https://cts-sct.ca/wp-content/uploads/2018/02/Evaluation-of-pts-w_ILD-paper.pdf
Kerri A. Johannson

Aug 21st, 2017 - Fibrotic ILD represents a large heterogeneous group of disorders that are challenging to diagnose. The evaluation of patients with fibrotic ILD should include a thorough history, physical examination, basic serological testing, pulmonary function.

Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fib...
http://www.thoracic.org/statements/resources/interstitial-lung-disease/animal-models-pulm-fibrosis.pdf
R. Gisli Jenkins

Apr 30th, 2017 - Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis using animal models, yet few of these compounds have replicated these beneficial effects in clinical trials. Given the challenges associated with performing clini.

see more →

Drugs  4 results see all →

Clinicaltrials.gov  11,297 results

"Hybrid Lung Transplantation" Combining Living Donor and Cadaveric Lung Transplants: Re...
https://doi.org/10.1016/j.transproceed.2021.04.019
Transplantation Proceedings; Kurosaki T, Oto T et. al.

Jun 13th, 2021 - We present 2 cases of "hybrid lung transplant," which included sequentially implanting a living lobar graft to 1 side and a cadaveric graft to the other side. This procedure was approved by the institutional review board at Okayama University Hosp...

Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice ...
https://doi.org/10.1016/j.intimp.2021.107780
International Immunopharmacology; Xiong Y, Cui X et. al.

Jun 12th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible inflammatory disease with a high mortality rate and limited therapeutic options. This study explored the potential role and mechanisms of Dehydrocostus lactone (DHL) in the inflamma...

Non-canonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.
https://doi.org/10.1165/rcmb.2020-0499OC
American Journal of Respiratory Cell and Molecular Biology; Liu T, Gonzalez De Los Santos F et. al.

Jun 9th, 2021 - The Wnt/β-catenin pathway initiates a signaling cascade critical in cell differentiation and normal development of multiple organ systems. The reactivation of this pathway has been documented in experimental and human idiopathic pulmonary fibrosis...

Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic rev...
https://doi.org/10.1186/s12931-021-01760-6 10.1183/13993003.01653-2015 10.1007/s12325-018-0693-1 10.1183/13993003.02279-2019 10.1164/rccm.201807-1255ST 10.1016/S1357-2725(96)00141-0 10.1165/rcmb.2020-0373PS 10.1378/chest.123.6.2007 10.1111/j.1440-1843.2005.00742.x 10.1016/j.rmed.2009.08.013 10.1016/j.rmed.2008.11.001 10.1016/j.biopha.2017.11.101 10.1038/s41591-018-0087-6 10.1007/s13205-020-02278-2 10.1038/s41467-019-10839-0 10.1159/000489668 10.1183/13993003.01188-2019 10.1001/jama.283.15.2008 10.1016/j.jclinepi.2009.06.005 10.1016/j.jclinepi.2007.10.007 10.1093/ije/dyn188 10.1136/bmj.315.7109.629 10.1016/j.rmed.2011.08.022 10.1378/chest.14-0041 10.1097/MD.0000000000005239 10.1183/09031936.00217614 10.1093/aje/152.4.307 10.1111/imj.15191 10.3389/fpubh.2020.00196 10.2337/dc07-1464 10.1159/000050509 10.2337/diacare.27.3.752 10.1016/j.metabol.2017.12.006 10.1378/chest.09-2622 10.1111/j.1464-5491.2010.03073.x 10.1007/s12013-014-0068-4 10.3346/jkms.2012.27.7.756 10.1159/000029331 10.1016/S0954-6111(97)90254-7 10.1007/BF00203738 10.1093/aje/kwi076 10.2337/diab.45.3.S77 10.1002/cbf.1418 10.1016/j.resp.2015.12.003 10.1016/j.jdiacomp.2006.08.004 10.1097/00003246-199608000-00004 10.1159/000111569 10.1183/09031936.00011810 10.1056/NEJM199411103311907 10.1513/pats.201203-023AW 10.1038/nrm3434 10.1016/S2213-8587(20)30365-X 10.1016/S2213-2600(20)30364-7 10.1016/j.cmet.2016.09.003 10.1164/rccm.201809-1700RR 10.1016/S2213-2600(17)30387-9 10.1038/ng.2609 10.1001/jama.2013.5827 10.1164/rccm.2009-040GL 10.1164/ajrccm.161.2.ats3-00
Respiratory Research; Bai L, Zhang L et. al.

Jun 9th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a chronic diffuse interstitial lung disease, of which the etiology has been poorly understood. Several studies have focused on the relationship between IPF and diabetes mellitus (DM) in the past years but hav...

The effect of pirfenidone on the prescription of antibiotics and antitussive drugs in p...
https://doi.org/10.1016/j.chest.2021.05.058
Chest Suzuki A, Sakaguchi H et. al.

Jun 8th, 2021 - The effect of pirfenidone on the prescription of antibiotics and antitussive drugs in patients with idiopathic pulmonary fibrosis: a post-hoc exploratory analysis of phase III clinical trial.|2021|Suzuki A,Sakaguchi H,Sakamoto K,Ebina M,Azuma A,|

see more →

News  425 results

Fast Five Quiz: Diagnosing Idiopathic Pulmonary Fibrosis
https://reference.medscape.com/viewarticle/909154

Feb 3rd, 2021 - Idiopathic pulmonary fibrosis (IPF) is the most common form of chronic, progressive fibrosing interstitial pneumonia of unknown origin. The histopathology and radiological findings of IPF are the same as those of usual interstitial pneumonia (UIP)...

PPI Use Not Associated With Improved Survival in Idiopathic Pulmonary Fibrosis
https://www.staging.medscape.com/viewarticle/936990

Sep 7th, 2020 - Takeaway In patients with idiopathic pulmonary fibrosis (IPF), the use of proton pump inhibitors (PPIs) is not associated with improved survival and reduced incidence of respiratory-related hospitalisation compared with non-use. Why this matters F...

PPI Use Not Associated With Improved Survival in Idiopathic Pulmonary Fibrosis
https://www.medscape.com/viewarticle/936990

Sep 7th, 2020 - Takeaway In patients with idiopathic pulmonary fibrosis (IPF), the use of proton pump inhibitors (PPIs) is not associated with improved survival and reduced incidence of respiratory-related hospitalisation compared with non-use. Why this matters F...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.medscape.com/viewarticle/925460_5

Jul 12th, 2020 - An increased prevalence of both OSA and GERD has been noted in patients with IPF. However, OSA has not been found to be a risk factor for GERD among patients with IPF. The use of GERD medications has been associated with longer survival times and ...

Fast Five Quiz: Idiopathic Pulmonary Fibrosis Comorbidities and Complications
https://reference.medscape.com/viewarticle/925460_6

Jul 12th, 2020 - Approximately 30% of patients with IPF have comorbid emphysema. The presence of comorbid emphysema does not disqualify patients with IPF for consideration or evaluation for lung transplantation. Comorbid emphysema is more commonly seen in men with...

see more →

Patient Education  23 results see all →